GLP-3 RT (RETATRUTIDE) Description: GLP-3 RT (Retatrutide) is an investigational unimolecular triple agonist of the glucagon-like peptide-1 receptor (GLP-1R), glucose-dependent insulinotropic polypeptide receptor (GIPR), and glucagon receptor (GCGR)
The rapid growth of the global overweight and diabetes population has given birth to the 100 billion market of GLP-1 drugs, and has also pushed its upstream API industry into a golden age
These receptors play a big role in signalling when you're full and supporting balanced digestion and metabolism
In certain amounts, prebiotic fiber can activate the release of GLP-1 (Glucagon-Like Peptide-1), a hormone that helps regulate appetite, slow stomach emptying, and promote feelings of fullness
There's also some emerging interest in whether GLP-1 medications themselves reduce the desire to drink, and many of my patients notice they simply want less alcohol than they used to
Moira has lost 10kg (22lb)